Finance

Beta
Lists
LNTH:NASDAQ
Lantheus Holdings Inc
၁၀၃.၈၆ US$
+၀.၆၅%
(+၀.၆၇) 1D
ဇွန် ၁၈, GMT-၄ ၁၆:၀၀:၀၂  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for LNTH...
Open
၁၀၄.၂၁ US$
High
၁၀၅.၀၀ US$
Low
၁၀၂.၉၇ US$
Mkt. cap
၆၇၆.၁၉ ဋေ
Avg. vol.
၁.၀၅ သန်း
Volume
၀.၀၀
P/E ratio
၂၅.၀၇
52-wk high
၁၀၇.၉၉ US$
52-wk low
၄၇.၂၇ US$
EPS
၄.၁၄ US$
Beta
-၀.၀၃
Shares outstanding
၆.၅၁ ကုဋေ
No. of employees
၁ ထောင်
Open
၁၀၄.၂၁ US$
High
၁၀၅.၀၀ US$
Low
၁၀၂.၉၇ US$
Mkt. cap
၆၇၆.၁၉ ဋေ
Avg. vol.
၁.၀၅ သန်း
Volume
၀.၀၀
P/E ratio
၂၅.၀၇
52-wk high
၁၀၇.၉၉ US$
52-wk low
၄၇.၂၇ US$
EPS
၄.၁၄ US$
Beta
-၀.၀၃
Shares outstanding
၆.၅၁ ကုဋေ
No. of employees
၁ ထောင်
Analyst outlook
Analyst Ratings
Based on 9 analysts giving stock ratings to LNTH in the past 3 months
Buy
Buy
6
Hold
2
Sell
1
12 month forecast
Based on 9 Wall Street analysts offering 12 month price targets for LNTH in the last 3 months.
Highest
Current ၁၀၃.၈၆ US$
၁၁၅.၀၀ US$ (+၁၀.၇၃%)
Average
၁၀၅.၁၅ US$ (+၁.၂၄%)
Lowest
၉၄.၀၀ US$ (-၉.၄၉%)
News stories
From sources across the web
Seeking Alpha
Seeking Alpha
·
ပြီးခဲ့သည့် ၁ ရက်
Lantheus: The Turnaround Is Working, But The Easy Money Has Been Made (NASDAQ:LNTH)
Profile
Lantheus, headquartered in Billerica, Massachusetts, is a company in the radiopharmaceuticals business. It has strategic partnerships with Bayer, Novartis, Regeneron as well as GE Healthcare and Siemens Healthineers. Lantheus Holding, which became a NASDAQ company in 2015, is the parent company of Lantheus Medical Imaging, Inc., Progenics Pharmaceuticals, Inc. and EXINI Diagnostics AB. Lantheus has offices in Massachusetts, New Jersey, Canada and Sweden. Brian Markison has served as the company's CEO since March 1, 2024, following the retirement of Mary Anne Heino, who had led Lantheus for the preceding decade. Wikipedia
About Lantheus Holdings Inc
CEO-
Employees၁.၁၉ ထောင်
Founded၁၉၅၆
HeadquartersNorth Billerica, မက်ဆာချူးဆက်ပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
၂၀၂၅ ဇွန်
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
Revenue
၃၇.၈၀ ကုဋေ
၃၈.၄၀ ကုဋေ
၄၀.၆၈ ကုဋေ
၃၇.၇၃ ကုဋေ
Cost of goods sold
၁၃.၇၀ ကုဋေ
၁၆.၁၆ ကုဋေ
၁၆.၅၉ ကုဋေ
၁၄.၆၄ ကုဋေ
Cost of revenue
၁၃.၇၀ ကုဋေ
၁၆.၁၆ ကုဋေ
၁၆.၅၉ ကုဋေ
၁၄.၆၄ ကုဋေ
Research and development expenses
၄.၅၅ ကုဋေ
၄.၈၀ ကုဋေ
၄.၇၅ ကုဋေ
၃.၉၄ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၁၀.၇၆ ကုဋေ
၁၃.၀၇ ကုဋေ
၁၁.၅၈ ကုဋေ
၁၀.၉၉ ကုဋေ
Operating expense
၁၅.၃၀ ကုဋေ
၁၇.၈၈ ကုဋေ
၁၆.၃၃ ကုဋေ
၁၄.၉၂ ကုဋေ
Total operating expenses
၂၉.၀၁ ကုဋေ
၃၄.၀၄ ကုဋေ
၃၂.၉၂ ကုဋေ
၂၉.၅၆ ကုဋေ
Operating income
၈.၈၀ ကုဋေ
၄.၃၆ ကုဋေ
၇.၇၆ ကုဋေ
၈.၁၇ ကုဋေ
Other non operating income
၂.၄၀ သောင်း
-၇.၉၈ သိန်း
-၉.၀၀ ထောင်
-၄.၆၂ သိန်း
EBT including unusual items
၁၀.၄၅ ကုဋေ
၄.၂၄ ကုဋေ
၇.၀၄ ကုဋေ
၁၅.၆၄ ကုဋေ
EBT excluding unusual items
၈.၉၉ ကုဋေ
၄.၁၂ ကုဋေ
၇.၅၂ ကုဋေ
၈.၂၅ ကုဋေ
Income tax expense
၂.၅၈ ကုဋေ
၁.၄၆ ကုဋေ
၁.၆၃ ကုဋေ
၃.၈၀ ကုဋေ
Effective tax rate
၂၄.၆၅%
၃၄.၄၇%
၂၃.၁၃%
၂၄.၂၉%
Other operating expenses
-
-
-
-
Net income
၇.၈၈ ကုဋေ
၂.၇၈ ကုဋေ
၅.၄၁ ကုဋေ
၁၁.၈၄ ကုဋေ
Net profit margin
၂၀.၈၃%
၇.၂၃%
၁၃.၃၀%
၃၁.၃၈%
Earnings per share
၁.၅၇
၁.၂၇
၁.၆၇
၁.၄၆
Interest and investment income
၇.၂၁ သန်း
၃.၆၂ သန်း
၃.၀၇ သန်း
၄.၉၇ သန်း
Interest expense
-၄.၉၂ သန်း
-၄.၉၅ သန်း
-၅.၀၈ သန်း
-၄.၈၆ သန်း
Net interest expenses
၂.၃၀ သန်း
-၁.၃၃ သန်း
-၂.၀၀ သန်း
၁.၀၅ သိန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
၁၀.၁၂ ကုဋေ
၆.၄၀ ကုဋေ
၁၀.၀၄ ကုဋေ
၁၀.၄၄ ကုဋေ
Gain or loss from assets sale
-
-
-၅.၀၀ သန်း
-၅.၉၃ ကုဋေ
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more